Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

por Blasi, Miriam, Eichhorn, Martin E., Christopoulos, Petros, Winter, Hauke, Heußel, Claus Peter, Herth, Felix J., El Shafie, Rami, Kriegsmann, Katharina, Kriegsmann, Mark, Stenzinger, Albrecht, Bischoff, Helge, Thomas, Michael, Kuon, Jonas
Publicado 2022

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

por Bernhardt, Denise, Aufderstrasse, Sophie, König, Laila, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Shafie, Rami A El, Hörner-Rieber, Juliane, Kappes, Jutta, Thomas, Michael, Herth, Felix, Steins, Martin, Debus, Jürgen, Rieken, Stefan
Publicado 2018

Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with n...

por Brueckl, Wolfgang M., Reck, Martin, Rittmeyer, Achim, Kollmeier, Jens, Wesseler, Claas, Wiest, Gunther H., Christopoulos, Petros, Stenzinger, Albrecht, Tufman, Amanda, Hoffknecht, Petra, Ulm, Bernhard, Reich, Fabian, Ficker, Joachim H., Laack, Eckart
Publicado 2021

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

por Angeles, Arlou Kristina, Christopoulos, Petros, Yuan, Zhao, Bauer, Simone, Janke, Florian, Ogrodnik, Simon John, Reck, Martin, Schlesner, Matthias, Meister, Michael, Schneider, Marc A., Dietz, Steffen, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Publicado 2021

Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression

por Rajakumar, Timothy, Horos, Rastislav, Kittner, Paul, Kahraman, Mustafa, Sikosek, Tobias, Hinkfoth, Franziska, Tikk, Kaja, Mercaldo, Nathaniel D., Stenzinger, Albrecht, Rabe, Klaus F., Reck, Martin, Thomas, Michael, Christopoulos, Petros, Steinkraus, Bruno R.
Publicado 2022

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

por Fink, Christoph A., Weykamp, Fabian, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Lang, Kristin, König, Laila, Hörner-Rieber, Juliane, Thomas, Michael, Steins, Martin, El-Shafie, Rami A., Rieken, Stefan, Bernhardt, Denise, Debus, Jürgen
Publicado 2023

Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies

por Christopoulos, Petros, Dietz, Steffen, Angeles, Arlou K., Rheinheimer, Stephan, Kazdal, Daniel, Volckmar, Anna-Lena, Janke, Florian, Endris, Volker, Meister, Michael, Kriegsmann, Mark, Zemojtel, Thomasz, Reck, Martin, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Publicado 2021

Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospec...

por Kriegsmann, Katharina, Zgorzelski, Christiane, Muley, Thomas, Christopoulos, Petros, Thomas, Michael, Winter, Hauke, Eichhorn, Martin, Eichhorn, Florian, von Winterfeld, Moritz, Herpel, Esther, Goeppert, Benjamin, Stenzinger, Albrecht, Herth, Felix J. F., Warth, Arne, Kriegsmann, Mark
Publicado 2021

Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report

por Ball, Markus, Christopoulos, Petros, Kirchner, Martina, Allgäuer, Michael, Brandt, Regine, Winter, Hauke, Heußel, Claus Peter, Herth, Felix, Fröhling, Stefan, Savai, Rajkumar, Kriegsmann, Mark, Schirmacher, Peter, Peters, Solange, Thomas, Michael, Stenzinger, Albrecht, Kazdal, Daniel
Publicado 2022

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer

por Kian, Waleed, Christopoulos, Petros, Remilah, Areen A., Levison, Esther, Dudnik, Elizabeth, Shalata, Walid, Krayim, Bilal, Marei, Ranin, Yakobson, Alexander, Faehling, Martin, Kahala, Dolev, Sara Granot, Inbal, Levitas, Dina, Peled, Nir, Roisman, Laila C.
Publicado 2022

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer

por Bozorgmehr, Farastuk, Kazdal, Daniel, Chung, Inn, Kirchner, Martina, Magios, Nikolaus, Kriegsmann, Mark, Allgäuer, Michael, Klotz, Laura V., Muley, Thomas, El Shafie, Rami A., Fischer, Jürgen R., Faehling, Martin, Stenzinger, Albrecht, Thomas, Michael, Christopoulos, Petros
Publicado 2021

Distinct immune-effector and metabolic profile of CD8(+) T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors

por Benesova, Karolina, Kraus, Franziska Viktoria, Carvalho, Rui A, Lorenz, Holger, Hörth, Christian H, Günther, Janine, Klika, Karel D, Graf, Jürgen, Diekmann, Leonore, Schank, Timo, Christopoulos, Petros, Hassel, Jessica C, Lorenz, Hanns-Martin, Souto-Carneiro, Margarida
Publicado 2022

Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Inser...

por Christopoulos, Petros, Girard, Nicolas, Proto, Claudia, Soares, Marta, Lopez, Pilar Garrido, van der Wekken, Anthonie J., Popat, Sanjay, Diels, Joris, Schioppa, Claudio A., Sermon, Jan, Rahhali, Nora, Pick-Lauer, Corinna, Adamczyk, Agnieszka, Penton, James, Wislez, Marie
Publicado 2023

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program

por Frost, Nikolaj, Christopoulos, Petros, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jürgen, Gütz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian, Griesinger, Frank
Publicado 2021

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors

por Rheinheimer, Stephan, Heussel, Claus-Peter, Mayer, Philipp, Gaissmaier, Lena, Bozorgmehr, Farastuk, Winter, Hauke, Herth, Felix J., Muley, Thomas, Liersch, Stephan, Bischoff, Helge, Kriegsmann, Mark, El Shafie, Rami A., Stenzinger, Albrecht, Thomas, Michael, Kauczor, Hans-Ulrich, Christopoulos, Petros
Publicado 2020

Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib

por Li, Jingjing, Zhang, Bin, Zhang, Yu, Xu, Feng, Zhang, Zhenfa, Shao, Lin, Yan, Chunhe, Ulivi, Paola, Denis, Marc G., Christopoulos, Petros, Thomas de Montpréville, Vincent, Bernicker, Eric H., van der Wekken, Anthonie J., Wang, Changli, Yue, Dongsheng
Publicado 2021

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer

por Daniello, Lea, Elshiaty, Mariam, Bozorgmehr, Farastuk, Kuon, Jonas, Kazdal, Daniel, Schindler, Hannah, Shah, Rajiv, Volckmar, Anna-Lena, Lusky, Fabienne, Diekmann, Leonore, Liersch, Stephan, Faehling, Martin, Muley, Thomas, Kriegsmann, Mark, Benesova, Karolina, Stenzinger, Albrecht, Thomas, Michael, Christopoulos, Petros
Publicado 2021

Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach

por Klotz, Laura V., Hoffmann, Hans, Shah, Rajiv, Eichhorn, Florian, Gruenewald, Christiane, Bulut, Elena L., Griffo, Raffaella, Muley, Thomas, Christopoulos, Petros, Baum, Philip, Huber, Peter, Safi, Seyer, Kriegsmann, Marc, Thomas, Michael, Bischoff, Helge, Winter, Hauke, Eichhorn, Martin E.
Publicado 2022

Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer

por Dietz, Steffen, Christopoulos, Petros, Gu, Lisa, Volckmar, Anna-Lena, Endris, Volker, Yuan, Zhao, Ogrodnik, Simon J., Zemojtel, Tomasz, Heussel, Claus-Peter, Schneider, Marc A., Meister, Michael, Muley, Thomas, Reck, Martin, Schlesner, Matthias, Thomas, Michael, Stenzinger, Albrecht, Sültmann, Holger
Publicado 2019

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Admin...

por Eichkorn, Tanja, Bozorgmehr, Farastuk, Regnery, Sebastian, Dinges, Lisa A., Kudak, Andreas, Bougatf, Nina, Weber, Dorothea, Christopoulos, Petros, Muley, Thomas, Kobinger, Sonja, König, Laila, Hörner-Rieber, Juliane, Adeberg, Sebastian, Heussel, Claus Peter, Thomas, Michael, Debus, Jürgen, El Shafie, Rami A.
Publicado 2020